Stokkevåg C - Search Results

1

Combined RBE and OER optimization in proton therapy with FLUKA based on EF5-PET.

Henjum H, Dahle TJ, Mairani A, Pilskog S, Stokkevåg C, Boer CG, Redalen KR, Minn H, Malinen E, Ytre-Hauge KS. Henjum H, et al. Among authors: stokkevag c. J Appl Clin Med Phys. 2023 Sep;24(9):e14014. doi: 10.1002/acm2.14014. Epub 2023 May 10. J Appl Clin Med Phys. 2023. PMID: 37161820 Free PMC article.

2

Estimated risk of radiation-induced cancer following paediatric cranio-spinal irradiation with electron, photon and proton therapy.

Stokkevåg CH, Engeseth GM, Ytre-Hauge KS, Röhrich D, Odland OH, Muren LP, Brydøy M, Hysing LB, Szostak A, Palmer MB, Petersen JB. Stokkevåg CH, et al. Acta Oncol. 2014 Aug;53(8):1048-57. doi: 10.3109/0284186X.2014.928420. Epub 2014 Jul 14. Acta Oncol. 2014. PMID: 25017376

3

Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer.

Stokkevåg CH, Engeseth GM, Hysing LB, Ytre-Hauge KS, Ekanger C, Muren LP. Stokkevåg CH, et al. Acta Oncol. 2015;54(9):1317-25. doi: 10.3109/0284186X.2015.1061691. Epub 2015 Jul 31. Acta Oncol. 2015. PMID: 26230629

4

Modelling of organ-specific radiation-induced secondary cancer risks following particle therapy.

Stokkevåg CH, Fukahori M, Nomiya T, Matsufuji N, Engeseth GM, Hysing LB, Ytre-Hauge KS, Rørvik E, Szostak A, Muren LP. Stokkevåg CH, et al. Radiother Oncol. 2016 Aug;120(2):300-6. doi: 10.1016/j.radonc.2016.07.001. Epub 2016 Jul 13. Radiother Oncol. 2016. PMID: 27424291

5

A phenomenological biological dose model for proton therapy based on linear energy transfer spectra.

Rørvik E, Thörnqvist S, Stokkevåg CH, Dahle TJ, Fjaera LF, Ytre-Hauge KS. Rørvik E, et al. Med Phys. 2017 Jun;44(6):2586-2594. doi: 10.1002/mp.12216. Epub 2017 May 22. Med Phys. 2017. PMID: 28295379

6

Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer.

Fjæra LF, Li Z, Ytre-Hauge KS, Muren LP, Indelicato DJ, Lassen-Ramshad Y, Engeseth GM, Brydøy M, Mairani A, Flampouri S, Dahl O, Stokkevåg CH. Fjæra LF, et al. Acta Oncol. 2017 Jun;56(6):763-768. doi: 10.1080/0284186X.2017.1314007. Epub 2017 Apr 19. Acta Oncol. 2017. PMID: 28423966

7

Monte Carlo simulations of a low energy proton beamline for radiobiological experiments.

Dahle TJ, Rykkelid AM, Stokkevåg CH, Mairani A, Görgen A, Edin NJ, Rørvik E, Fjæra LF, Malinen E, Ytre-Hauge KS. Dahle TJ, et al. Acta Oncol. 2017 Jun;56(6):779-786. doi: 10.1080/0284186X.2017.1289239. Epub 2017 Feb 22. Acta Oncol. 2017. PMID: 28464743

8

The influence of inter-fractional anatomy variation on secondary cancer risk estimates following radiotherapy.

Stokkevåg CH, Engeseth GM, Hysing LB, Ytre-Hauge KS, Muren LP. Stokkevåg CH, et al. Phys Med. 2017 Oct;42:271-276. doi: 10.1016/j.ejmp.2017.09.125. Epub 2017 Sep 21. Phys Med. 2017. PMID: 28941739

9

Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.

Pedersen J, Petersen JBB, Stokkevåg CH, Ytre-Hauge KS, Flampouri S, Li Z, Mendenhall N, Muren LP. Pedersen J, et al. Acta Oncol. 2017 Nov;56(11):1413-1419. doi: 10.1080/0284186X.2017.1373198. Epub 2017 Oct 17. Acta Oncol. 2017. PMID: 29037095

10

Exploration and application of phenomenological RBE models for proton therapy.

Rørvik E, Fjæra LF, Dahle TJ, Dale JE, Engeseth GM, Stokkevåg CH, Thörnqvist S, Ytre-Hauge KS. Rørvik E, et al. Phys Med Biol. 2018 Sep 13;63(18):185013. doi: 10.1088/1361-6560/aad9db. Phys Med Biol. 2018. PMID: 30102240

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters